These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8693501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP, Traineau R, Tuveri R, Ravera N, Bureau C, Gluckman E, Benbunan M, Loiseau P.
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RW, Simmonds P, Chapel H.
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status.
    Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E.
    Blood; 1997 Aug 01; 90(3):1309-14. PubMed ID: 9242566
    [Abstract] [Full Text] [Related]

  • 10. At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C.
    Widell A, Zhang YY, Andersson-Gäre B, Hammarström L.
    Transfusion; 1997 Mar 01; 37(3):313-20. PubMed ID: 9122906
    [Abstract] [Full Text] [Related]

  • 11. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM, Baron MJ, Bresee JS, Schneider LC.
    Pediatrics; 1996 Aug 01; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.
    Björkander J, Fasth A, Widell A.
    Clin Ther; 1996 Aug 01; 18 Suppl B():73-82. PubMed ID: 8930444
    [Abstract] [Full Text] [Related]

  • 13. HCV infection in patients with primary defects of immunoglobulin production.
    Quinti I, Pandolfi F, Paganelli R, el Salman D, Giovannetti A, Rosso R, Oliva A, Rainaldi L, Aiuti F.
    Clin Exp Immunol; 1995 Oct 01; 102(1):11-6. PubMed ID: 7554376
    [Abstract] [Full Text] [Related]

  • 14. The viral safety of intravenous immune globulin.
    Yap PL.
    Clin Exp Immunol; 1996 May 01; 104 Suppl 1():35-42. PubMed ID: 8625542
    [Abstract] [Full Text] [Related]

  • 15. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A, Doerr HW, Scharrer I, Weber B.
    J Med Virol; 1997 Sep 01; 53(1):25-30. PubMed ID: 9298728
    [Abstract] [Full Text] [Related]

  • 16. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S, Fielding JF.
    Ital J Gastroenterol Hepatol; 1997 Feb 01; 29(1):47-50. PubMed ID: 9265578
    [Abstract] [Full Text] [Related]

  • 17. Effect of immune globulin on the prevention of experimental hepatitis C virus infection.
    Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, Kuo G, Spelbring JE, Meeks E, Sinha S, Carson DA.
    J Infect Dis; 1996 Apr 01; 173(4):822-8. PubMed ID: 8603959
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin.
    Taliani G, Guerra E, Rosso R, Badolato MC, Luzi G, Sacco G, Lecce R, De Bac C, Aiuti F.
    Transfusion; 1995 Feb 01; 35(2):103-7. PubMed ID: 7825204
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A, Walker E.
    Lancet; 1995 Aug 05; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of hepatitis C in patients with primary antibody deficiency.
    Webster AD, Brown D, Franz A, Dusheiko G.
    Clin Exp Immunol; 1996 Jan 05; 103(1):5-7. PubMed ID: 8565286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.